Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb:66:109490.
doi: 10.1016/j.cellsig.2019.109490. Epub 2019 Dec 2.

Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD

Affiliations
Review

Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD

Allison L Brill et al. Cell Signal. 2020 Feb.

Abstract

Polycystin 2 (PC2) is one of two main protein types responsible for the underlying etiology of autosomal dominant polycystic kidney disease (ADPKD), the most prevalent monogenic renal disease in the world. This debilitating and currently incurable condition is caused by loss-of-function mutations in PKD2 and PKD1, the genes encoding for PC2 and Polycystin 1 (PC1), respectively. Two-hit mutation events in these genes lead to renal cyst formation and eventual kidney failure, the main hallmarks of ADPKD. Though much is known concerning the physiological consequences and dysfunctional signaling mechanisms resulting from ADPKD development, to best understand the requirement of PC2 in maintaining organ homeostasis, it is important to recognize how PC2 acts under normal conditions. As such, an array of work has been performed characterizing the endogenous function of PC2, revealing it to be a member of the transient receptor potential (TRP) channel family of proteins. As a TRP protein, PC2 is a nonselective, cation-permeant, calcium-sensitive channel expressed in all tissue types, where it localizes primarily on the endoplasmic reticulum (ER), primary cilia, and plasma membrane. In addition to its channel function, PC2 interacts with and acts as a regulator of a number of other channels, ultimately further affecting intracellular signaling and leading to dysfunction in its absence. In this review, we describe the biophysical and physiological properties of PC2 as a cation channel and modulator of intracellular calcium channels, along with how these properties are altered in ADPKD.

Keywords: ADPKD; Calcium; Calcium channel; Polycystic kidney disease; Polycystin 2; TRP; TRPP1; TRPP2.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: BEE is a cofounder of Osmol Therapeutics, a company that is targeting neuronal calcium sensor 1 (NCS1) for therapeutic purposes. ALB has no potential conflicts of interest.

Figures

Figure 1:
Figure 1:. Polycystin 2 is a membrane-bound transient receptor potential channel
A) Schematic depicting the topology of a full-length human PC2 monomer. PC2 contains six transmembrane helices and cytosolic N- and C-termini. Serine phosphorylation sites can be found in both termini; from N- to C-terminus: Ser76, 801, 812, and 829. The unique ‘tetragonal opening for polycystins’ (TOP, pink) domain between transmembrane regions 1–2 is rich in N-glycosylation sites: from N- to C-terminus: Asn299, 305, 328, 362, and 375. The characteristic voltage-sensing domain (VSD, yellow) of PC2 spans transmembrane helices 1–4. PC2’s pore-forming loop containing pore helices 1 and 2 (P, green) sits between transmembrane helices 5 and 6 (blue) and allows the transfer of Ca2+ from the ER lumen to the cytosol. The C-terminal tail of PC2 contains a Ca2+-binding EF hand, ER retention tag, and coiled-coil domain. Numbers depict amino acid locations. B) Structure of a truncated PC2 monomer (PDB: 5MKF) containing amino acids K215-K695, without the cytosolic N- or C-termini. Yellow highlights the VSD; pink highlights the TOP domain; green highlights the pore helices; blue highlights transmembrane helices 5–6. N-glycosylated residues within the TOP domain are labeled and highlighted in teal. C) Top-down (luminal) view of truncated PC2 (PDB: 5K47) highlighting the location of these same domains within a homotetrameric quaternary structure. Opaque coloring highlights a single monomer.
Figure 2:
Figure 2:. Polycystin 2 interacts with ion channels to modulate intracellular Ca2+ signaling
Diagram depicting PC2/channel interactions in a healthy cell, and how normal Ca2+ signaling prevents the hyper-proliferation and -survival observed in PC2-deficient cells. PC2 acts to release ER Ca2+ through its intrinsic channel activity, or through its interactions with the InsP3R or RyR. The PC2/InsP3R interaction at the ER-mitochondrial interface serves to reduce the levels of mitochondrial Ca2+ uptake, preventing overload and apoptotic initiation. The PC2/PC1 and PC2/TRPV4 interactions on the primary cilium allow for mechanically stimulated Ca2+ influx. PC2/TRPC1 and PC2/TRPV4/TRPC1 heterocomplexes on the plasma membrane facilitate cation transport into the cytoplasm. The proper maintenance of cytosolic Ca2+ levels acts to limit the activity of AC5/6, thus regulating the cellular levels of cAMP. Without proper Ca2+ signaling, cAMP levels are enhanced, leading to the activation of PKA and numerous downstream pathways to promote cell proliferation and survival. Polycystin 2 (PC2); polycystin 1 (PC1); transient receptor potential cation channel subfamily V member 4 (TRPV4); transient receptor potential cation channel subfamily C member 1 (TRPC1); ryanodine receptor (RyR2); inositol 1,4,5-trisphosphate receptor (InsP3R); endoplasmic reticulum (ER); mitochondrion (Mito); adenylyl cyclase 5/6 (AC5/6); adenosine triphosphate (ATP); cyclic adenosine monophosphate (cAMP); protein kinase A (PKA).

References

    1. Harris PC & Torres VE Polycystic kidney disease. Annual review of medicine 60, 321–337, doi:10.1146/annurev.med.60.101707.125712 (2009). - DOI - PMC - PubMed
    1. Kimberling WJ et al. Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13–q23. Genomics 18, 467–472, doi:10.1016/S0888-7543(11)80001-7 (1993). - DOI - PubMed
    1. Peters DJM et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nature Genetics 5, 359–362, doi:10.1038/ng1293359 (1993). - DOI - PubMed
    1. The International Polycystic Kidney Disease, C. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81, 289–298, doi:10.1016/0092-8674(95)90339-9 (1995). - DOI - PubMed
    1. Al-Bhalal L & Akhtar M Molecular basis of autosomal dominant polycystic kidney disease. Advances in anatomic pathology 12, 126–133 (2005). - PubMed

Publication types